NCT00469157View on ClinicalTrials.gov

Refractive Surgery and Optive Compatibility Study

PHASE4CompletedINTERVENTIONAL

Enrollment

92

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions

Dry Eye Syndromes

Interventions

DRUG

Optive

Optive 30ml- (in the eye) Instill one in each eye twice daily starting one week after surgery

Trial Locations (1)

92831

TLC, Fullerton

Sponsors

Lead Sponsor

Innovative Medical

All Listed Sponsors

lead

Innovative Medical

INDUSTRY